Insights Management Platform

Sales & Marketing

Within3’s disease community analytics provide an understanding of influence within a disease community – not just expertise.

News

Agios Pharma has said it will halt clinical development of tebapivat, a PK activator that had reached phase 2 testing in sickle cell disease.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.